Meta-analysis of the efficacy of digital therapies in children with attention-deficit hyperactivity disorder
Fan He, Yan‐Jie Qi, Yuanyue Zhou, Aihua Cao, Xin Yue, Shuanfeng Fang et al. · 2023 · 44 citationsRead the paper
Background: Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder that commonly occurs in childhood. The aim of this meta-analysis was to summarize the available evidence for the efficacy of digital therapeutics in children and adolescents with ADHD. Methods: We searched the MEDLINE, EMBASE, Cochrane Library (Cochrane Database of Systematic Reviews), and Web of Science (science and social science citation index) databases for relevant studies and used Stata 15.0 software to carry out the meta-analysis. Results: A total of 31 studies involving 2169 participants (1665 boys and 504 girls) aged 4-17 years old were included in the final analysis. The meta-analysis results showed that digital interventions improved the symptoms of inattention with an effect value of -0.20 (95% confidence interval [CI] -0.36, -0.04) and decreased the continuous performance task (CPT) reaction time (effect, -0.40, 95% CI -0.73, -0.07) in ADHD patients. The score for impulsive hyperactivity was slightly decreased (effect, -0.07, 95% CI -0.23, 0.09). Moreover, executive function was improved (effect, 0.71, 95% CI 0.37, 1.04). The capability of working memory appeared to be increased (effect, 0.48, 95% CI 0.21, 0.76) between the two groups. Visual appraisal of the sensitivity analysis suggested the absence of heterogeneity, and no obvious publication bias was detected. Discussion: Based on the existing literature evidence, we conclude that digital therapy can be a promising therapeutic strategy for ADHD patients.
What the full text shows
Tested in real conditions- Improvement in inattention symptoms — effect -0.20 (95% CI -0.36, -0.04) (Pediatric ADHD patients aged 4-17)
- Decrease in Continuous Performance Task (CPT) reaction time — effect -0.40 (95% CI -0.73, -0.07) (Pediatric ADHD patients aged 4-17)
- Improvement in executive function — effect 0.71 (95% CI 0.37, 1.04) (Pediatric ADHD patients aged 4-17)
- Increase in working memory capability — effect 0.48 (95% CI 0.21, 0.76) (Pediatric ADHD patients aged 4-17)
- Decrease in impulsive hyperactivity — effect -0.07 (95% CI -0.23, 0.09) (Pediatric ADHD patients aged 4-17)
- Setup
- 31 studies involving 2,169 participants (1,665 boys, 504 girls) aged 4-17 years.
- How
- Meta-analysis of 31 studies following PRISMA guidelines. Researchers extracted data on core ADHD symptoms and cognitive functions from clinical trials and prospective studies.
- Limitations
- Lack of consensus on outcome measures for efficacy · Limited validation of digital devices in non-English languages · Lack of standardized protocols and categorization based on active components · Potential for video game addiction and adverse effects like headache or dizziness
Summarized by Gemma 4 from the open-access full text · 9 Oct 2026. Read it